PL356366A1 - Zastosowanie pochodnych witaminy D w leczeniu osteoporozy i związanych z nią chorób kości oraz nowepochodne witaminy D3 - Google Patents
Zastosowanie pochodnych witaminy D w leczeniu osteoporozy i związanych z nią chorób kości oraz nowepochodne witaminy D3Info
- Publication number
- PL356366A1 PL356366A1 PL01356366A PL35636601A PL356366A1 PL 356366 A1 PL356366 A1 PL 356366A1 PL 01356366 A PL01356366 A PL 01356366A PL 35636601 A PL35636601 A PL 35636601A PL 356366 A1 PL356366 A1 PL 356366A1
- Authority
- PL
- Poland
- Prior art keywords
- derivatives
- vitamin
- osteoporosis
- treatment
- well
- Prior art date
Links
- 208000020084 Bone disease Diseases 0.000 title 1
- 208000001132 Osteoporosis Diseases 0.000 title 1
- 150000003710 vitamin D derivatives Chemical class 0.000 title 1
- 150000003704 vitamin D3 derivatives Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/24—All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Transplantation (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17942600P | 2000-01-31 | 2000-01-31 | |
| PCT/DK2001/000069 WO2001056981A1 (en) | 2000-01-31 | 2001-01-31 | Use of vitamin d-derivatives in the treatment of osteoporosis and related bone disorders, as well as novel vitamin d3-derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL356366A1 true PL356366A1 (pl) | 2004-06-28 |
Family
ID=22656548
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL01356366A PL356366A1 (pl) | 2000-01-31 | 2001-01-31 | Zastosowanie pochodnych witaminy D w leczeniu osteoporozy i związanych z nią chorób kości oraz nowepochodne witaminy D3 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7071178B2 (pl) |
| EP (1) | EP1255732A1 (pl) |
| JP (1) | JP2003521531A (pl) |
| KR (1) | KR20020080396A (pl) |
| CN (1) | CN1396910A (pl) |
| AU (1) | AU776755B2 (pl) |
| BR (1) | BR0107969A (pl) |
| CA (1) | CA2399083A1 (pl) |
| HU (1) | HUP0204258A3 (pl) |
| IL (1) | IL150527A0 (pl) |
| MX (1) | MXPA02007339A (pl) |
| PL (1) | PL356366A1 (pl) |
| RU (1) | RU2253455C2 (pl) |
| WO (1) | WO2001056981A1 (pl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007505882A (ja) * | 2003-09-19 | 2007-03-15 | ファイザー・プロダクツ・インク | 脆弱、筋損傷又はサルコペニアの治療のための２−アルキリデン−１９−ノル−ビタミンｄ誘導体 |
| NZ545393A (en) * | 2003-09-19 | 2009-10-30 | Wisconsin Alumni Res Found | 2-Alkylidene-19-nor-vitamin D derivatives for the treatment of osteopenia or male osteoporosis |
| JP2010524973A (ja) * | 2007-04-18 | 2010-07-22 | ジョンズ ホプキンス ユニバーシティ | カルシトリオールの低カルシウム血性、高抗増殖性類似体 |
| US8377913B2 (en) * | 2007-11-20 | 2013-02-19 | Abbvie Inc. | Vitamin D receptor activators and methods of making |
| AU2010208323B2 (en) * | 2009-01-27 | 2016-03-10 | Berg Llc | Vitamin D3 and analogs thereof for alleviating side effects associated with chemotherapy |
| CN106008301B (zh) * | 2016-05-24 | 2017-12-26 | 中国医药集团总公司四川抗菌素工业研究所 | 26‑甲基‑25‑羟基维生素d3化合物及其制备方法和应用 |
| KR101983654B1 (ko) * | 2018-07-24 | 2019-05-29 | 한국과학기술원 | Cfc 증후군 환자의 발달 저해를 완화할 수 있는 치료용 조성물 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3163836A (en) * | 1952-04-14 | 1964-12-29 | Sumitomo Electric Industries | Coaxial conductor having parallel connected stranded layers of different pitch for equalizing inductance and current distribution |
| US3588317A (en) * | 1968-11-08 | 1971-06-28 | Simplex Wire & Cable Co | Shielded cable |
| IL67153A (en) * | 1981-11-02 | 1986-12-31 | Res Inst Medicine Chem | Intermediates in the production of vitamin d analogues and method for their production |
| DE3524082A1 (de) * | 1985-07-05 | 1987-01-08 | Bbc Brown Boveri & Cie | Supraleitende faser und verfahren zu deren herstellung |
| GB9007236D0 (en) * | 1990-03-30 | 1990-05-30 | Leo Pharm Prod Ltd | Chemical compounds |
| KR960013798B1 (ko) * | 1992-04-24 | 1996-10-10 | 재단법인 한국전자통신연구소 | 평면 도파로형 공간 스위치 |
| DE19520589A1 (de) * | 1995-06-06 | 1996-12-12 | Siemens Ag | Wechselstromkabel mit verseilten elektrischen Leitern |
| US5929385A (en) * | 1996-05-10 | 1999-07-27 | The Furukawa Electric Co., Ltd | AC oxide superconductor wire and cable |
-
2001
- 2001-01-31 JP JP2001556831A patent/JP2003521531A/ja active Pending
- 2001-01-31 EP EP01948978A patent/EP1255732A1/en not_active Withdrawn
- 2001-01-31 HU HU0204258A patent/HUP0204258A3/hu unknown
- 2001-01-31 PL PL01356366A patent/PL356366A1/pl not_active Application Discontinuation
- 2001-01-31 AU AU28329/01A patent/AU776755B2/en not_active Ceased
- 2001-01-31 CN CN01804344A patent/CN1396910A/zh active Pending
- 2001-01-31 IL IL15052701A patent/IL150527A0/xx unknown
- 2001-01-31 RU RU2002123409/15A patent/RU2253455C2/ru not_active IP Right Cessation
- 2001-01-31 WO PCT/DK2001/000069 patent/WO2001056981A1/en not_active Ceased
- 2001-01-31 US US09/787,548 patent/US7071178B2/en not_active Expired - Fee Related
- 2001-01-31 MX MXPA02007339A patent/MXPA02007339A/es unknown
- 2001-01-31 CA CA002399083A patent/CA2399083A1/en not_active Abandoned
- 2001-01-31 KR KR1020027009792A patent/KR20020080396A/ko not_active Ceased
- 2001-01-31 BR BR0107969-7A patent/BR0107969A/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1396910A (zh) | 2003-02-12 |
| BR0107969A (pt) | 2002-10-29 |
| US7071178B2 (en) | 2006-07-04 |
| EP1255732A1 (en) | 2002-11-13 |
| HUP0204258A2 (hu) | 2003-04-28 |
| MXPA02007339A (es) | 2004-08-11 |
| AU2832901A (en) | 2001-08-14 |
| RU2253455C2 (ru) | 2005-06-10 |
| KR20020080396A (ko) | 2002-10-23 |
| HUP0204258A3 (en) | 2005-03-29 |
| US20040069523A1 (en) | 2004-04-15 |
| AU776755B2 (en) | 2004-09-23 |
| JP2003521531A (ja) | 2003-07-15 |
| CA2399083A1 (en) | 2001-08-09 |
| WO2001056981A1 (en) | 2001-08-09 |
| RU2002123409A (ru) | 2004-03-10 |
| IL150527A0 (en) | 2003-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0401023A3 (en) | Use of flibanserin in the treatment of sexual disorders | |
| GB0007193D0 (en) | Treatment of movrmrnt disorders | |
| AU2001266152A1 (en) | Novel substituted nitrocatechols, their use in the treatment of some central andperipheral nervous system disorders and pharmaceutical compositions containing them | |
| MXPA03008634A (es) | Nuevos compuestos de dihidropirimidina ciano sustituidos y su uso para tratar enfermedades. | |
| MXPA03003741A (es) | Metodos y composiciones para el tratamiento de enfermedades oftalmicas. | |
| GB0108671D0 (en) | Skin treatment | |
| ZA200307475B (en) | Carbamate compounds for use in the treatment of pain. | |
| IL164887A0 (en) | Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith | |
| IL150527A0 (en) | Use of vitamin d-derivatives in the treatment of osteoporosis and related bone disorders, as well as novel vitamin d3-derivatives | |
| IL156045A0 (en) | Compositions containing gangliosides for use in the treatment of skin disorders | |
| AU2002360531A8 (en) | Methods and compositions to treat cardiovascular disease using 1419, 58765 and 2201 | |
| EP1328264A4 (en) | USE OF ESTRAMUSTINE PHOSPHATE IN THE TREATMENT OF BONE METASTASE | |
| AU2002210763A1 (en) | Use of 1-ebio in the treatment of bipolar disorders | |
| AU2003255843A1 (en) | 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain | |
| IL162053A0 (en) | Method for the treatment of bone disorders | |
| EP1539100A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN DISORDERS | |
| AU2001228330A1 (en) | Vitamin d-derivatives and their use in treating osteoporosis and related bone disorders | |
| EP1589985A4 (en) | METHOD AND COMPOSITIONS FOR TREATING PAIN AND PAIN DISORDERS USING 16386, 15402, 21165, 1423, 636, 12303, 21425, 27410, 38554, 38555, 55063, 57145, 59914, 94921, 16852, 33260, 58573, 30911, 85913 , 14303, 16816, 17827 OR 32620 | |
| GB0106316D0 (en) | Apparatus for use in the treatment of hair | |
| EP1450666A4 (en) | METHOD AND COMPOSITIONS FOR TREATING HEART CIRCULAR ILLNESSES USING 139,258,1261,1486,2398,2414,7660,8587,10183,10550,12680,17921,32248,60489 OR 93804 | |
| AU2002358267A1 (en) | Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908 | |
| SI1425008T1 (sl) | Uporaba substituiranih aminometilkromanov za zdravljenje stranskih ucinkov nevroleptikov | |
| AU2003217432A8 (en) | Angiopoietin-1 in the treatment of disease | |
| EP1517912A4 (en) | METHODS AND COMPOSITIONS FOR TREATING PAIN AND PAIN DISEASES USING GENES 577, 20739 OR 57145 | |
| AU2003247094A8 (en) | Enhancing the effect of radioimmunotherapy in the treatment of tumors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |